首页> 外文期刊>Journal of enzyme inhibition and medicinal chemistry. >Discovery and antibacterial study of potential PPK1 inhibitors against uropathogenic E. coli
【24h】

Discovery and antibacterial study of potential PPK1 inhibitors against uropathogenic E. coli

机译:潜在的PPK1抑制剂对尿鼠肿瘤大肠杆菌的发现和抗菌研究

获取原文
           

摘要

Novel antibacterial agents are urgently needed to address the infections caused by multi-drug resistantbacteria. Urinary tract infections are common infectious diseases in clinical. Most of these infections arecaused by drug-resistant uropathogenic Escherichia coli. PPK1 is an essential kinase for bacterial motility,biofilm formation, quorum sensing, and virulence factors in the expression of uropathogenic E. coli. In thepresent study, two small molecules potentially targeting PPK1 were discovered through virtual screeningand biological assays. The in vitro and in vivo results suggested that the interaction of these compoundswith PPK1 can disrupt biofilm formation of uropathogenic E. coli and reduce invasive ability and resistanceto oxidative stress of this strain. Moreover, the compounds exhibit good antibacterial bacterial activity inthe mice with urinary tract infection. Taken together, our findings could provide a new chemotype for thedevelopment of antibacterials targeting PPK1.
机译:迫切需要新型抗菌剂来解决多药物抗菌抗菌引起的感染。尿路感染是临床中常见的传染病。这些感染中的大部分感染被耐药尿羟疗法大肠杆菌。 PPK1是用于细菌运动,生物膜形成,法定感测和表达尿羟致原型大肠杆菌的毒力因子的基本激酶。在实验研究中,通过虚拟筛查和生物测定发现可能靶向PPK1的两种小分子。体外和体内结果表明,这些化合物PPK1的相互作用可以破坏生物膜形成的尿羟化物大肠杆菌,并降低该菌株的侵入力和抗血液氧化应激。此外,该化合物表现出良好的抗菌细菌活性,尿路感染小鼠。在一起,我们的研究结果可以为靶向PPK1的抗菌剂进行新的趋化型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号